Baillie Gifford & Co
AZN icon

Baillie Gifford & Co’s AstraZeneca AZN Stock Holding History

Baillie Gifford & Co’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-228
Closed -$31.7K – 309
2023
Q1 		$31.7K Buy
228
+28
+14% +$3.77K ﹤0.01% 309
2022
Q4 		$27.1K Hold
200
– – ﹤0.01% 321
2022
Q3 		$22K Hold
200
– – ﹤0.01% 319
2022
Q2 		$26K Hold
200
– – ﹤0.01% 317
2022
Q1 		$27K Hold
200
– – ﹤0.01% 327
2021
Q4 		$23K Hold
200
– – ﹤0.01% 358
2021
Q3 		$24K Buy
+200
New +$23.3K ﹤0.01% 342

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return